H. Pak

Type de document

Articles (8)

Co-auteur

Date

Source

Mot-clé

spectacle (5) analyse (5) cancer (5) Cancer (5) Cancer (5) Analysis (5) Peptides (4) Ligands (4) carte (3) ligne (3) Identification (3) Human beings (3) Immunotherapy (3) Identification (3) Histocompatibility antigens (3) Antigens (3) Identification (3) Immunotherapy (3) protéine (2) mutation (2) modèle (2) méthodologie (2) abords (agglomération) (2) Methodology (2) Dendritic cells (2) Tumors (2) Tissues (2) Prophecies (2) Patients (2) Modeling (2)

Documents écrit par H. Pak (8) | parle de H. Pak (0)

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
A.I. Kraemer et al.
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
H. Ebrahimi-Nik et al. (5 nov. 2021)
CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
G. Forlani et al. (2021)
Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
H. Pak et al. (2021)
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
H. Ebrahimi-Nik et al. (20 juin 2019)
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.
C. Chong et al.
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.
M. Bassani-Sternberg et al. (2017)